-
Vaccine development research newly started in Nagasaki,
the birthplace of vaccines in Japan.
Topics
-
Introduction to Infectious Disease Epidemiology and Modelling – Short Course Report
Thursday 24 August 2023
-
Introduction to Infectious Disease Epidemiology and Modelling – Short Course Report
Thursday 24 August 2023
There is no registered post.
About us
Vaccine Research and Development Center (VRDC), DEJIMA Infectious Disease Research Alliance (DIDA), Nagasaki University is one of the four synergistic centers selected for the Project 'Japan Initiative for World-leading Vaccine Research and Development Centers'. It aims to promote the development of vaccines against highly pathogenic and tropical pathogens that have been studied by Nagasaki University and to develop vaccines against infectious diseases that pose a threat to mankind.
Careers
Publications
12924226
items
1
apa
5
default
desc
year
1
115
https://dida.nagasaki-u.ac.jp/dida_wp/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-dff0b264c7620a51483a868af280454d%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22UQAS2CIM%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Ngwe%20Tun%20et%20al.%22%2C%22parsedDate%22%3A%222023-08%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ENgwe%20Tun%2C%20M.%20M.%2C%20Kyaw%2C%20A.%20K.%2C%20Nwe%2C%20K.%20M.%2C%20Myaing%2C%20S.%20S.%2C%20Win%2C%20Y.%20T.%2C%20Inoue%2C%20S.%2C%20Takamatsu%2C%20Y.%2C%20Urano%2C%20T.%2C%20Thu%2C%20H.%20M.%2C%20Hmone%2C%20S.%20W.%2C%20Thant%2C%20K.%20Z.%2C%20%26amp%3B%20Morita%2C%20K.%20%282023%29.%20Burden%20of%20Chikungunya%20Virus%20Infection%20during%20an%20Outbreak%20in%20Myanmar.%20%3Ci%3EViruses%3C%5C%2Fi%3E%2C%20%3Ci%3E15%3C%5C%2Fi%3E%288%29%2C%201734.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fv15081734%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.3390%5C%2Fv15081734%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Burden%20of%20Chikungunya%20Virus%20Infection%20during%20an%20Outbreak%20in%20Myanmar%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mya%20Myat%22%2C%22lastName%22%3A%22Ngwe%20Tun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aung%20Kyaw%22%2C%22lastName%22%3A%22Kyaw%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Khine%20Mya%22%2C%22lastName%22%3A%22Nwe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Su%20Su%22%2C%22lastName%22%3A%22Myaing%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ye%20Thu%22%2C%22lastName%22%3A%22Win%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shingo%22%2C%22lastName%22%3A%22Inoue%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuki%22%2C%22lastName%22%3A%22Takamatsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Takeshi%22%2C%22lastName%22%3A%22Urano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hlaing%20Myat%22%2C%22lastName%22%3A%22Thu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Saw%20Wutt%22%2C%22lastName%22%3A%22Hmone%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kyaw%20Zin%22%2C%22lastName%22%3A%22Thant%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kouichi%22%2C%22lastName%22%3A%22Morita%22%7D%5D%2C%22abstractNote%22%3A%22Chikungunya%20virus%20%28CHIKV%29%20infection%20is%20a%20re-emerging%20arboviral%20disease%20with%20no%20approved%20vaccine%2C%20although%20numerous%20options%20are%20in%20development.%20Before%20vaccine%20implementation%2C%20disease%20burden%2C%20affected%20age%20group%2C%20and%20hospitalization%20rate%20information%20should%20be%20documented.%20In%202019%2C%20a%20sizeable%20outbreak%20of%20the%20East%20Central%20South%20African%20genotype%20of%20CHIKV%20occurred%20in%20Myanmar%2C%20and%20during%20this%20period%2C%20a%20cross-sectional%20study%20was%20conducted%20in%20two%20regions%2C%20Mandalay%20and%20Yangon%2C%20to%20examine%20the%20molecular%20and%20seropositivity%20rate%20of%20the%20CHIKV%20infection.%20The%20participants%20%281124%29%20included%20dengue-suspected%20pediatric%20patients%2C%20blood%20donors%2C%20and%20healthy%20volunteers%2C%20who%20were%20assessed%20using%20molecular%20assays%20%28quantitative%20real-time%20RT-PCR%29%2C%20serological%20tests%20%28anti-CHIKV%20IgM%20capture%20and%20IgG%20indirect%20enzyme-linked%20immunosorbent%20assays%29%2C%20and%20neutralization%20tests.%20The%20tests%20confirmed%20the%20following%20positivity%20rates%3A%2011.3%25%20%28127%5C%2F1124%29%20for%20the%20molecular%20assay%2C%2012.4%25%20%28139%5C%2F1124%29%20for%20the%20anti-CHIKV%20IgM%20Ab%2C%2044.5%25%20%28500%5C%2F1124%29%20for%20the%20anti-CHIKV%20IgG%20Ab%2C%20and%2046.3%25%20%28520%5C%2F1124%29%20for%20the%20CHIKV%20neutralizing%20Ab.%20The%20highest%20rate%20for%20the%20molecular%20test%20occurred%20with%20the%20dengue-suspected%20pediatric%20patients.%20The%20seroprevalence%20rate%20through%20natural%20infection%20was%20higher%20in%20the%20healthy%20volunteers%20and%20blood%20donors%20than%20that%20in%20the%20pediatric%20patients.%20The%20results%20of%20this%20study%20will%20help%20stakeholders%20determine%20the%20criteria%20for%20choosing%20appropriate%20recipients%20when%20a%20CHIKV%20vaccine%20is%20introduced%20in%20Myanmar.%22%2C%22date%22%3A%222023%5C%2F8%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.3390%5C%2Fv15081734%22%2C%22ISSN%22%3A%221999-4915%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.mdpi.com%5C%2F1999-4915%5C%2F15%5C%2F8%5C%2F1734%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-03-05T02%3A53%3A52Z%22%7D%7D%2C%7B%22key%22%3A%22NAN2WXZF%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Balingit%20et%20al.%22%2C%22parsedDate%22%3A%222024-02-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EBalingit%2C%20J.%20C.%2C%20Dimamay%2C%20M.%20P.%20S.%2C%20Suzuki%2C%20R.%2C%20Matsuda%2C%20M.%2C%20Xayavong%2C%20D.%2C%20Ngwe%20Tun%2C%20M.%20M.%2C%20Matias%2C%20R.%20R.%2C%20Natividad%2C%20F.%20F.%2C%20Moi%2C%20M.%20L.%2C%20Takamatsu%2C%20Y.%2C%20Culleton%2C%20R.%2C%20Buerano%2C%20C.%20C.%2C%20%26amp%3B%20Morita%2C%20K.%20%282024%29.%20Role%20of%20pre-existing%20immunity%20in%20driving%20the%20dengue%20virus%20serotype%202%20genotype%20shift%20in%20the%20Philippines%3A%20A%20retrospective%20analysis%20of%20serological%20data.%20%3Ci%3EInternational%20Journal%20of%20Infectious%20Diseases%3C%5C%2Fi%3E%2C%20%3Ci%3E139%3C%5C%2Fi%3E%2C%2059%26%23x2013%3B68.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ijid.2023.11.025%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ijid.2023.11.025%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Role%20of%20pre-existing%20immunity%20in%20driving%20the%20dengue%20virus%20serotype%202%20genotype%20shift%20in%20the%20Philippines%3A%20A%20retrospective%20analysis%20of%20serological%20data%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jean%20Claude%22%2C%22lastName%22%3A%22Balingit%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20Pierre%20S.%22%2C%22lastName%22%3A%22Dimamay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ryosuke%22%2C%22lastName%22%3A%22Suzuki%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mami%22%2C%22lastName%22%3A%22Matsuda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dalouny%22%2C%22lastName%22%3A%22Xayavong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mya%20Myat%22%2C%22lastName%22%3A%22Ngwe%20Tun%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ronald%20R.%22%2C%22lastName%22%3A%22Matias%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Filipinas%20F.%22%2C%22lastName%22%3A%22Natividad%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Meng%20Ling%22%2C%22lastName%22%3A%22Moi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yuki%22%2C%22lastName%22%3A%22Takamatsu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%22%2C%22lastName%22%3A%22Culleton%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Corazon%20C.%22%2C%22lastName%22%3A%22Buerano%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kouichi%22%2C%22lastName%22%3A%22Morita%22%7D%5D%2C%22abstractNote%22%3A%22Objective%5CnThe%20invasion%20of%20dengue%20virus%20%28DENV%29-2%20Cosmopolitan%20genotype%20into%20the%20Philippines%2C%20where%20the%20Asian%20II%20genotype%20previously%20circulated%20challenges%20the%20principle%20of%20dengue%20serotype-specific%20immunity.%20Assessment%20of%20antibodies%20in%20this%20population%20may%20provide%20a%20mechanistic%20basis%20for%20how%20new%20genotypes%20emerge%20in%20dengue-endemic%20areas.%5CnMethods%5CnWe%20evaluated%20the%20neutralizing%20antibody%20%28nAb%29%20and%20antibody-dependent%20enhancement%20%28ADE%29%20responses%20against%20the%20two%20genotypes%20using%20archived%20serum%20samples%20collected%20from%20333%20patients%20with%20confirmed%20dengue%20in%20Metro%20Manila%2C%20Philippines%2C%20before%2C%20during%2C%20and%20after%20the%20introduction%20of%20the%20Cosmopolitan%20genotype.%20We%20quantified%20nAb%20titers%20in%20baby%20hamster%20kidney%20%28BHK-21%29%20cells%20with%20or%20without%20the%20Fc%5Cu03b3%20receptor%20IIA%20%28Fc%5Cu03b3RIIA%29%20to%20detect%20the%20capacity%20of%20virus-antibody%20complexes%20to%20neutralize%20or%20enhance%20DENV.%5CnResults%5CnThe%20nAb%20potency%20of%20the%20archived%20serum%20samples%20against%20the%20two%20genotypes%20was%20greatly%20affected%20by%20the%20presence%20of%20Fc%5Cu03b3RIIA.%20We%20found%20significant%20differences%20in%20nAb%20titers%20between%20the%20two%20genotypes%20in%20BHK-21%20cells%20with%20Fc%5Cu03b3RIIA%20%28P%5Cu00a0%3C0.0001%29.%20The%20archived%20serum%20samples%20were%20incapable%20of%20fully%20neutralizing%20the%20Cosmopolitan%20genotype%2C%20but%20instead%20strongly%20promoted%20its%20ADE%20compared%20to%20the%20Asian%20II%20genotype%20%28P%5Cu00a0%3C0.0001%29.%5CnConclusion%5CnThese%20results%20reinforce%20the%20role%20of%20pre-existing%20immunity%20in%20driving%20genotype%20shifts.%20Our%20finding%20that%20specific%20genotypes%20exhibit%20differing%20susceptibilities%20to%20ADE%20by%20cross-reactive%20antibodies%20may%20have%20implications%20for%20dengue%20vaccine%20development.%22%2C%22date%22%3A%222024-02-01%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ijid.2023.11.025%22%2C%22ISSN%22%3A%221201-9712%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS1201971223007865%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-03-05T02%3A53%3A12Z%22%7D%7D%2C%7B%22key%22%3A%22E525XR6W%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Paul%20et%20al.%22%2C%22parsedDate%22%3A%222024-06-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EPaul%2C%20K.%20M.%20M.%2C%20Simpson%2C%20S.%20V.%2C%20Nundu%2C%20S.%20S.%2C%20Arima%2C%20H.%2C%20%26amp%3B%20Yamamoto%2C%20T.%20%282024%29.%20Genetic%20diversity%20of%20glutamate-rich%20protein%20%28GLURP%29%20in%20Plasmodium%20falciparum%20isolates%20from%20school-age%20children%20in%20Kinshasa%2C%20DRC.%20%3Ci%3EParasitology%20International%3C%5C%2Fi%3E%2C%20%3Ci%3E100%3C%5C%2Fi%3E%2C%20102866.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.parint.2024.102866%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.parint.2024.102866%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Genetic%20diversity%20of%20glutamate-rich%20protein%20%28GLURP%29%20in%20Plasmodium%20falciparum%20isolates%20from%20school-age%20children%20in%20Kinshasa%2C%20DRC%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kambale%20Mathe%20Mowa%22%2C%22lastName%22%3A%22Paul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shirley%20V.%22%2C%22lastName%22%3A%22Simpson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sabin%20S.%22%2C%22lastName%22%3A%22Nundu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hiroaki%22%2C%22lastName%22%3A%22Arima%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Taro%22%2C%22lastName%22%3A%22Yamamoto%22%7D%5D%2C%22abstractNote%22%3A%22Malaria%20infections%20in%20school-age%20children%20further%20make%20it%20difficult%20to%20control%20the%20disease%27s%20spread.%20Moreover%2C%20the%20genetic%20diversity%20of%20glutamate-rich%20protein%2C%20potentially%20a%20candidate%20for%20vaccine%20development%2C%20has%20not%20yet%20been%20investigated%20in%20the%20Democratic%20Republic%20of%20Congo.%20Therefore%2C%20we%20aimed%20to%20assess%20the%20genetic%20diversity%20of%20the%20immunodominant%20C-terminal%20repetitive%20region%20%28R2%29%20of%20Plasmodium%20falciparum%20glutamate-rich%20protein%20gene%20%28pfglurp%29%20among%20school-age%20children%20living%20in%20Kinshasa%2C%20DRC.%20We%20conducted%20nested%20PCR%20targeting%20R2%20of%20pfglurp%20and%20the%20amplicon%20were%20directly%20sequenced.%20We%20summarized%20the%20prevalence%20of%20mutations%20of%20bases%20and%20amino%20acids%20and%20indicated%20the%20amino%20acid%20repeat%20sequence%20in%20the%20R2%20region%20by%20the%20unit%20code.%20We%20then%20statistically%20analyzed%20whether%20there%20was%20a%20relationship%20between%20the%20number%20of%20mutations%20in%20the%20pfglurp%20gene%20and%20attributes.%20In%20221%20samples%2C%20haplotype%201%20was%20the%20most%20common%20%28n%5Cu00a0%3D%5Cu00a0137%2C%2061.99%25%29%2C%20with%20the%20same%20sequence%20as%20the%203D7%20strain.%20Regarding%20the%20number%20of%20base%20mutations%2C%20it%20was%20higher%20in%20urban%20areas%20than%20rural%20areas%20%28p%5Cu00a0%3D%5Cu00a00.0363%29.%20When%20genetic%20neutrality%20was%20tested%20using%20data%20from%20171%20samples%20of%20the%20single%20strain%2C%20Tajima%27s%20D%20was%20%5Cu22121.857%20%28p%5Cu00a0%3D%5Cu00a00.0059%29.%20In%20addition%2C%20FST%20as%20the%20genetic%20distance%20between%20all%20attributes%20was%20very%20small%20and%20no%20significant%20difference%20was%20observed.%20This%20study%20clarified%20the%20genetic%20mutation%20status%20and%20relevant%20patient%20attributes%20among%20School-age%20children%20in%20the%20DRC.%20We%20found%20that%20urban%20areas%20are%20more%20likely%20to%20harbour%20pfglurp%20mutations.%20Future%20research%20needs%20to%20clarify%20the%20reason%20and%20mechanism%20involved.%22%2C%22date%22%3A%222024-06-01%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.parint.2024.102866%22%2C%22ISSN%22%3A%221383-5769%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.sciencedirect.com%5C%2Fscience%5C%2Farticle%5C%2Fpii%5C%2FS1383576924000175%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-03-03T23%3A35%3A46Z%22%7D%7D%2C%7B%22key%22%3A%22PUJINUPP%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mogasale%20et%20al.%22%2C%22parsedDate%22%3A%222024-02-05%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EMogasale%2C%20V.%2C%20Sinha%2C%20A.%2C%20John%2C%20J.%2C%20Farooqui%2C%20H.%2C%20Ray%2C%20A.%2C%20Chantler%2C%20T.%2C%20Mogasale%2C%20V.%2C%20Dhoubhadel%2C%20B.%20G.%2C%20Edmunds%2C%20W.%20J.%2C%20Clark%2C%20A.%20D.%2C%20%26amp%3B%20Abbas%2C%20K.%20%282024%29.%20%3Ci%3EResearch%20Priorities%20to%20Support%20Typhoid%20Conjugate%20Vaccine%20Decision-Making%20in%20India%3A%20Evidence%20Assessment%20and%20Stakeholder%20Survey%3C%5C%2Fi%3E%20%28SSRN%20Scholarly%20Paper%204714399%29.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2139%5C%2Fssrn.4714399%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2139%5C%2Fssrn.4714399%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Research%20Priorities%20to%20Support%20Typhoid%20Conjugate%20Vaccine%20Decision-Making%20in%20India%3A%20Evidence%20Assessment%20and%20Stakeholder%20Survey%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vijayalaxmi%22%2C%22lastName%22%3A%22Mogasale%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anish%22%2C%22lastName%22%3A%22Sinha%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jacob%22%2C%22lastName%22%3A%22John%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Habib%22%2C%22lastName%22%3A%22Farooqui%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Arindam%22%2C%22lastName%22%3A%22Ray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tracey%22%2C%22lastName%22%3A%22Chantler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vittal%22%2C%22lastName%22%3A%22Mogasale%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bhim%20Gopal%22%2C%22lastName%22%3A%22Dhoubhadel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%20John%22%2C%22lastName%22%3A%22Edmunds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20D.%22%2C%22lastName%22%3A%22Clark%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaja%22%2C%22lastName%22%3A%22Abbas%22%7D%5D%2C%22abstractNote%22%3A%22Background%3A%20India%20is%20a%20typhoid%20fever%20high-burden%20country.%20In%202022%2C%20the%20National%20Technical%20Advisory%20Group%20on%20Immunisation%20recommended%20introducing%20typhoid%20conjugate%20vaccination%20%28TCV%29%20into%20the%20Universal%20Immunisation%20Programme.%20Our%20study%20aims%20to%20identify%20research%20priorities%20to%20support%20ongoing%20TCV%20decision-making%20in%20India.Methods%3A%20We%20identified%2045%20evidence%20factors%20for%20TCV%20decision-making%20in%20India%20by%20adapting%20WHO%5Cu2019s%20Evidence-to-Recommendation%20criteria.%20We%20assigned%20an%20evidence%20gap%20score%20for%20each%20evidence%20factor%20from%200%20%28low%29%20to%204%20%28high%29%20based%20on%20the%20availability%2C%20sufficiency%2C%20quality%2C%20breadth%2C%20and%20applicability%20of%20evidence%20identified%20in%20a%20literature%20review%20%28end%20date%2030th%20November%202023%29.%20We%20assigned%20each%20evidence%20factor%20an%20importance%20score%20based%20on%20the%20results%20of%20an%20online%20survey%20among%20national%20stakeholders%20%28n%3D22%2C%201st%20July-31st%20October%202023%29%2C%20where%20they%20ranked%20the%20importance%20of%20seven%20WHO%5Cu2019s%20Evidence-to-Recommendation%20criteria%20and%20several%20evidence%20factors%20within%20them.%20Mean%20stakeholder%20rankings%20were%20rescaled%20into%20importance%20scores%20from%200%20%28low%29%20to%204%20%28high%29.%20The%20evidence%20gap%20score%20was%20added%20to%20the%20importance%20score%2C%20and%20the%20overall%20scores%20were%20used%20to%20identify%20research%20priorities.Findings%3A%20The%20evidence%20factors%20with%20the%20highest%20priority%20scores%20were%20the%20public%20perception%20of%20typhoid%20fever%2C%20vaccine%20budget%20impact%2C%20vaccine%20availability%2C%20socio-economic%20impact%2C%20fiscal%20space%2C%20antimicrobial%20resistance%20tracking%2C%20typhoid%20mortality%2C%20public%20perception%20of%20vaccine%2C%20immunisation%20managers%5Cu2019%20acceptance%2C%20and%20vaccine%20schedule%20preferences%20among%20caregivers.Interpretation%3A%20We%20have%20identified%20several%20priorities%20for%20TCV%20research%20in%20India.%20These%20priorities%20will%20evolve%20as%20new%20research%20studies%20and%20questions%20emerge%20about%20the%20optimal%20scheduling%2C%20roll-out%20and%20implementation%20of%20TCV%20in%20India.Funding%3A%20Nagasaki%20University%20WISE%20Programme.Declaration%20of%20Interest%3A%20The%20authors%20declare%20no%20competing%20interests.Ethical%20Approval%3A%20The%20research%20protocol%20for%20key%20stakeholders%5Cu2019%20survey%20was%20approved%20by%20the%20London%20School%20of%20Hygiene%20%26%20Tropical%20Medicine%20%28LSHTM%29%20Research%20Ethics%20Committee%20%28Ref.%20No%2028600%29%20and%20Institutional%20Ethics%20Committee%2C%20Indian%20Institute%20of%20Public%20Health%20%28IIPH%29%2C%20Gandhinagar%20%28Ref%3A%20TRC-IEC%20no%3A%2004%5C%2F2023-24%29.%22%2C%22genre%22%3A%22SSRN%20Scholarly%20Paper%22%2C%22repository%22%3A%22%22%2C%22archiveID%22%3A%224714399%22%2C%22date%22%3A%222024-02-05%22%2C%22DOI%22%3A%2210.2139%5C%2Fssrn.4714399%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fpapers.ssrn.com%5C%2Fabstract%3D4714399%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-03-03T23%3A34%3A26Z%22%7D%7D%2C%7B%22key%22%3A%22KTUVDI6B%22%2C%22library%22%3A%7B%22id%22%3A12924226%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kang%20et%20al.%22%2C%22parsedDate%22%3A%222023-11-01%22%2C%22numChildren%22%3A0%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EKang%2C%20H.%2C%20Auzenbergs%2C%20M.%2C%20Clapham%2C%20H.%20E.%2C%20Maure%2C%20C.%2C%20Kim%2C%20J.-H.%2C%20Salje%2C%20H.%2C%20Taylor%2C%20C.%2C%20Lim%2C%20A.%2C%20Clark%2C%20A.%20D.%2C%20Edmunds%2C%20W.%20J.%2C%20Sahastrabuddhe%2C%20S.%2C%20Brady%2C%20O.%2C%20%26amp%3B%20Abbas%2C%20K.%20%282023%29.%20%3Ci%3EChikungunya%20Seroprevalence%2C%20Force%20of%20Infection%2C%20and%20Prevalence%20of%20Chronic%20Disability%20in%20Endemic%20and%20Epidemic%20Settings%3A%20Systematic%20Review%2C%20Meta-Analysis%2C%20and%20Modelling%20Study%3C%5C%2Fi%3E%20%28SSRN%20Scholarly%20Paper%204617040%29.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2139%5C%2Fssrn.4617040%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.2139%5C%2Fssrn.4617040%3C%5C%2Fa%3E%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22preprint%22%2C%22title%22%3A%22Chikungunya%20Seroprevalence%2C%20Force%20of%20Infection%2C%20and%20Prevalence%20of%20Chronic%20Disability%20in%20Endemic%20and%20Epidemic%20Settings%3A%20Systematic%20Review%2C%20Meta-Analysis%2C%20and%20Modelling%20Study%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hyolim%22%2C%22lastName%22%3A%22Kang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Megan%22%2C%22lastName%22%3A%22Auzenbergs%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hannah%20E.%22%2C%22lastName%22%3A%22Clapham%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Clara%22%2C%22lastName%22%3A%22Maure%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jong-Hoon%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Henrik%22%2C%22lastName%22%3A%22Salje%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Taylor%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ahyoung%22%2C%22lastName%22%3A%22Lim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Andrew%20D.%22%2C%22lastName%22%3A%22Clark%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22W.%20John%22%2C%22lastName%22%3A%22Edmunds%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sushant%22%2C%22lastName%22%3A%22Sahastrabuddhe%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Oliver%22%2C%22lastName%22%3A%22Brady%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kaja%22%2C%22lastName%22%3A%22Abbas%22%7D%5D%2C%22abstractNote%22%3A%22Background%3A%20Chikungunya%20is%20an%20arboviral%20disease%20transmitted%20by%20Aedes%20aegypti%20and%20Aedes%20albopictus%20mosquitoes%2C%20and%20chikungunya%20outbreaks%20are%20exacerbated%20by%20climate%20change%20and%20globalisation.%20Our%20aim%20is%20to%20estimate%20chikungunya%20seroprevalence%2C%20force%20of%20infection%2C%20and%20prevalence%20of%20chronic%20disability%20and%20hospitalisation%20in%20endemic%20and%20epidemic%20settings.Methods%3A%20We%20conducted%20a%20systematic%20review%20of%20chikungunya%20seroprevalence%20surveys%20and%20fitted%20catalytic%20models%20to%20each%20survey%20to%20estimate%20location-specific%20force%20of%20infections%20%28FOIs%29.%20We%20also%20conducted%20a%20meta-analysis%20to%20estimate%20the%20proportions%20of%20chronically-disabled%20and%20hospitalised%20cases%20among%20lab-confirmed%20symptomatic%20chikungunya%20patients.Findings%3A%20We%20identified%2060%20seroprevalence%20and%20post-chikungunya%20symptom%20studies%20across%2038%20countries%20and%20classified%2017%20and%2059%20locations%20as%20endemic%20and%20epidemic%20settings%20respectively.%20The%20global%20long-term%20average%20FOI%20had%20a%20median%20value%20of%200.007%20%2895%25UI%3A0.003-0.01%29%20and%20varied%20from%200.0001%20%2895%25UI%3A%200.00004-0.0002%29%20to%200.113%20%2895%25UI%3A0.07-0.2%29.%20South%20Asia%20had%20the%20highest%20median%20long%20term%20average%20FOI%20of%200.0083%20%2895%25UI%3A%200.005-0.01%29%2C%20followed%20by%20Latin%20America%20and%20the%20Caribbean%20at%200.0080%20%2895%25UI%3A0.004-0.013%29%2C%20and%20Middle%20East%20registered%20the%20lowest%20at%200.001%20%2895%25UI%3A%200.0005-0.002%29.%20We%20estimated%2051%25%20%2895%25CI%3A%2045-58%25%29%20chronic%20disability%20rate%20and%204%25%20%2895%25CI%3A%203-5%25%29%20hospitalisation%20rate%20among%20lab-confirmed%20symptomatic%20chikungunya%20patients.Interpretation%3A%20We%20inferred%20subnational%20heterogeneity%20in%20FOI%20and%20transmission%20dynamics%20and%20identified%20both%20endemic%20and%20epidemic%20settings%20coexisting%20within%20countries%20such%20as%20Brazil%2C%20Ethiopia%2C%20and%20India.%20We%20observed%20higher%20long-term%20average%20FOI%20in%20epidemic%20settings%20than%20endemic%20settings.%20However%2C%20large%20outbreaks%20in%20epidemic%20settings%20with%20high%20FOI%20can%20experience%20similar%20levels%20of%20infections%20in%20the%20long-term%20as%20endemic%20settings.Funding%3A%20International%20Vaccine%20InstituteConflict%20of%20Interest%3A%20We%20declare%20no%20competing%20interests.%22%2C%22genre%22%3A%22SSRN%20Scholarly%20Paper%22%2C%22repository%22%3A%22%22%2C%22archiveID%22%3A%224617040%22%2C%22date%22%3A%222023-11-01%22%2C%22DOI%22%3A%2210.2139%5C%2Fssrn.4617040%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fpapers.ssrn.com%5C%2Fabstract%3D4617040%22%2C%22language%22%3A%22en%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222024-03-03T23%3A32%3A58Z%22%7D%7D%5D%7D
Ngwe Tun, M. M., Kyaw, A. K., Nwe, K. M., Myaing, S. S., Win, Y. T., Inoue, S., Takamatsu, Y., Urano, T., Thu, H. M., Hmone, S. W., Thant, K. Z., & Morita, K. (2023). Burden of Chikungunya Virus Infection during an Outbreak in Myanmar. Viruses, 15(8), 1734. https://doi.org/10.3390/v15081734
Balingit, J. C., Dimamay, M. P. S., Suzuki, R., Matsuda, M., Xayavong, D., Ngwe Tun, M. M., Matias, R. R., Natividad, F. F., Moi, M. L., Takamatsu, Y., Culleton, R., Buerano, C. C., & Morita, K. (2024). Role of pre-existing immunity in driving the dengue virus serotype 2 genotype shift in the Philippines: A retrospective analysis of serological data. International Journal of Infectious Diseases, 139, 59–68. https://doi.org/10.1016/j.ijid.2023.11.025
Paul, K. M. M., Simpson, S. V., Nundu, S. S., Arima, H., & Yamamoto, T. (2024). Genetic diversity of glutamate-rich protein (GLURP) in Plasmodium falciparum isolates from school-age children in Kinshasa, DRC. Parasitology International, 100, 102866. https://doi.org/10.1016/j.parint.2024.102866
Mogasale, V., Sinha, A., John, J., Farooqui, H., Ray, A., Chantler, T., Mogasale, V., Dhoubhadel, B. G., Edmunds, W. J., Clark, A. D., & Abbas, K. (2024). Research Priorities to Support Typhoid Conjugate Vaccine Decision-Making in India: Evidence Assessment and Stakeholder Survey (SSRN Scholarly Paper 4714399). https://doi.org/10.2139/ssrn.4714399
Kang, H., Auzenbergs, M., Clapham, H. E., Maure, C., Kim, J.-H., Salje, H., Taylor, C., Lim, A., Clark, A. D., Edmunds, W. J., Sahastrabuddhe, S., Brady, O., & Abbas, K. (2023). Chikungunya Seroprevalence, Force of Infection, and Prevalence of Chronic Disability in Endemic and Epidemic Settings: Systematic Review, Meta-Analysis, and Modelling Study (SSRN Scholarly Paper 4617040). https://doi.org/10.2139/ssrn.4617040